These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24497072)

  • 1. Realistic prediction of solid pharmaceutical oxidation products by using a novel forced oxidation system.
    Ueyama E; Tamura K; Mizukawa K; Kano K
    J Pharm Sci; 2014 Apr; 103(4):1184-93. PubMed ID: 24497072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel accelerated oxidative stability screening method for pharmaceutical solids.
    Zhu DA; Zhang GGZ; George KLST; Zhou D
    J Pharm Sci; 2011 Aug; 100(8):3529-3538. PubMed ID: 21520085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel peroxy radical based oxidative stressing system for ranking the oxidizability of drug substances.
    Harmon PA; Kosuda K; Nelson E; Mowery M; Reed RA
    J Pharm Sci; 2006 Sep; 95(9):2014-28. PubMed ID: 16850394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel markers to track oxidative polysorbate degradation in pharmaceutical formulations.
    Dahotre S; Tomlinson A; Lin B; Yadav S
    J Pharm Biomed Anal; 2018 Aug; 157():201-207. PubMed ID: 29803911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction system of oxidation reaction as a solid-state stress condition: applied to a pyrrole-containing pharmaceutical compound.
    Kawaguchi-Murakami Y; Fukutsu N; Kajiro T; Araki T; Murakami T; Kawasaki T; Kishi N; Konno M
    J Pharm Biomed Anal; 2009 Oct; 50(3):328-35. PubMed ID: 19497698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH control of nucleophilic/electrophilic oxidation.
    Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
    Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition metal-induced degradation of a pharmaceutical compound in reversed-phase liquid chromatographic analysis.
    Wang Q; He BL; Zhang J; Huang Y; Kleintop B; Raglione T
    J Pharm Biomed Anal; 2015; 111():288-96. PubMed ID: 25916912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of N-methylpyrrolidone as a cosolvent and oxidant in pharmaceutical stress testing.
    Reynolds DW; Galvani M; Hicks SR; Joshi BJ; Kennedy-Gabb SA; Kleinman MH; Parmar PZ
    J Pharm Sci; 2012 Feb; 101(2):761-76. PubMed ID: 22083665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solvent effects on the AIBN forced degradation of cumene: Implications for forced degradation practices.
    Nelson ED; Thompson GM; Yao Y; Flanagan HM; Harmon PA
    J Pharm Sci; 2009 Mar; 98(3):959-69. PubMed ID: 18623222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near UV and Visible Light Induce Iron-Dependent Photodegradation Reactions in Pharmaceutical Buffers: Mechanistic and Product Studies.
    Subelzu N; Schöneich C
    Mol Pharm; 2020 Nov; 17(11):4163-4179. PubMed ID: 32986444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
    Huang Y; Su BN; Marshall J; Miller SA
    J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxide formation in polysorbate 80 and protein stability.
    Ha E; Wang W; Wang YJ
    J Pharm Sci; 2002 Oct; 91(10):2252-64. PubMed ID: 12226852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.
    Lippold S; Koshari SHS; Kopf R; Schuller R; Buckel T; Zarraga IE; Koehn H
    J Pharm Biomed Anal; 2017 Jan; 132():24-34. PubMed ID: 27693757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation.
    Kranz W; Wuchner K; Corradini E; Berger M; Hawe A
    J Pharm Sci; 2019 Jun; 108(6):2022-2032. PubMed ID: 30639738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.
    Ji JA; Zhang B; Cheng W; Wang YJ
    J Pharm Sci; 2009 Dec; 98(12):4485-500. PubMed ID: 19455640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Effect of Histidine on Polysorbate 20 Stability: Mechanistic Studies.
    Zhang L; Yadav S; John Wang Y; Mozziconacci O; Schӧneich C
    Pharm Res; 2018 Jan; 35(2):33. PubMed ID: 29368235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time.
    Graf T; Abstiens K; Wedekind F; Elger C; Haindl M; Wurth C; Leiss M
    Eur J Pharm Biopharm; 2020 Jul; 152():318-326. PubMed ID: 32445968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
    Modhave DT; Handa T; Shah RP; Singh S
    J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple reversed phase high-performance liquid chromatography method for polysorbate 80 quantitation in monoclonal antibody drug products.
    Adamo M; Dick LW; Qiu D; Lee AH; Devincentis J; Cheng KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1865-70. PubMed ID: 20537600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.